XNCR

XencorF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

XNCR vs peer average

22/100

XNCR vs. peer average (F vs. C)

Grade spread

A 2 · B 1 · C 1 · D 3 · F 2

Graded peers loaded

Coverage

9 graded

100% of tracked

Peer overview

ABUS is the first available peer comparator.

Small-cap clinical biotech comp by size, but not a close operating peer; useful mainly as a sentiment/risk benchmark for binary development-stage names.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerABUSArbutus Biopharma

XNCR

Xencor

ABUS

Arbutus Biopharma

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs ABUS

XNCR / ABUS

Grade Position

Below peers

XNCR vs. peer average (F vs. C)

22/100

Momentum

ABUS

Value

XNCR

Sentiment

ABUS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs XNCR

ABUS

60/100

-2

GERN

100/100

-4

JANX

Janux Therapeutics Inc Common

40/100

-1

SANA

Sana Biotechnology Inc Common

20/100

Even

PCRX

Pacira Biosciences Inc Common

100/100

-4

ABUS is the first peer returned for this comparison set.